Background: The current clinical assessment of myocardial viability by myocardial contrast
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Introduction
Myocardial contrast echocardiography (MCE) has provided new insight into the assessment of myocardial viability in acute ischemic syndromes (1, 2) and in stable ischemic heart disease (3, 4) . However, the current clinical assessment of myocardial viability by MCE is based on visual interpretation of MCE images or on quantitative computer assisted processing. Visual interpretation of myocardial perfusion is subjective and requires experienced investigators (3) (4) (5) (6) (7) .
Quantitative analysis of myocardial perfusion using replenishment kinetics to fit exponential curves is, on the other hand, time consuming and provides low spatial resolution. Myocardial parametric imaging (MPI) is a new method which provides automated color-encoded quantification of myocardial blood flow and parametric imaging according to the relative degree of perfusion (8) (9) . The feasibility of myocardial parametric quantification to detect inducible ischemia has been currently demonstrated (8, 9) . However, there is still no published report on the value of MPI for myocardial viability assessment. The purpose of this study was to assess the value of MPI for viability detection in the experimental setting of acute infarction and in patients with stable ischemic heart disease.
Methods

Experimental studies
Experimental protocol. The experimental protocol was approved by the German Animal -5 -occlusion and after 2 hours of reperfusion (2) . Ultrasound images were performed in color-coded harmonic power pulse inversion (PPI) mode. The mechanical index (MI) was set between 0.14 and 0.18 and the dynamic range was set at "low". SonoVue ® (Bracco, Byk-Gulden, Konstanz, Germany) was applied as continuous intravenous infusion (60ml/h). When the myocardium of the left ventricle was fully opacified a brief pulse of higher mechanical index (flash) was transmitted to "clear" the myocardium from microbubbles. Returning immediately to low-power imaging, replenishment was visualized over 10 to 15 cardiac cycles. The risk area was identified as the area of severely reduced or absent myocardial opacification during LAD occlusion and determined by visually-and by MPI-guided planimetry. Similarly, perfusion defects at 2 hours of reperfusion were determined by planimetry as the area of severely reduced or absent myocardial opacification, 10-15 cardiac cycles after flash and expressed as percentage of the risk area (perfusion-defect-size-to-risk-area-ratio).
Histology. The LAD was reoccluded at the end of the experiment and Monastral blue dye (Sigma, St. Louis, MO) was injected into the left atrium to outline the area at risk as previously described (2 
Clinical studies
Patient population. The study population consisted of 34 consecutive patients with impaired left ventricular function (ejection fraction≤40%) due to ischemic heart disease, who were scheduled for revascularization. Two patients were excluded due to extremely poor echographic windows. The study was approved by the local ethics committee and all patients -6 -signed informed consent before their enrolment in the study. MCE studies were performed within 2 weeks before revascularization.
Two-dimensional echocardiography. Imaging was performed in standard apical views using an ATL HDI 5000. Regional function was assessed according to the 16-segment left ventricular model of the American Society of Echocardiography and graded from 1 (normal), 2 (hypokinesia), 3 (akinesia) to 4 (dyskinesia). Ejection fraction was quantified using the biplane
Simpson`s method (10) . Follow-up echocardiograms were obtained at 3 to 6 months of follow-up and recovery of regional function was defined as an improvement of ≥1 grade in wall motion.
Functional recovery deemed as the standard reference for myocardial viability (3-4, 11).
Real-time Myocardial Contrast Echocardiography. Perfusion imaging was performed similarly to experimental studies using low power imaging (4-7). Slow bolus injections of SonoVue ® (1.0 to 1.5 ml per bolus) were used to obtain optimal visualization of the left ventricle.
Visual analysis. Images were analyzed by 2 independent observers. Afterwards, a third independent observer proved the variability of the 2 first observers and resolved differences in opinion by consensus of all 3. Normally, it takes about 5 to 6 cycles at rest to completely replenish the ultrasound beam in systole after microbubble destruction (4, 7) . Therefore, for visual assessment of myocardial viability, readers interpreted interflash sequences concentrating on myocardial opacification in the first 5-6 end-systolic frames after Flash. Segmental opacification was graded using a semi-quantitative scale, as previously described (4-7):
3=homogenous, 2=mildly reduced, 1=severely reduced or absent. Segments with homogenous or mildly reduced opacification were judged as viable, whereas regions with severely reduced or absent opacification were judged as nonviable (4) . In order to prevent the effects of attenuation and lateral dropout from affecting interpretation, contrast defects were considered present only when the segment under question was entirely visualized from epicardium to endocardium. A slight oblique orientation of the four-and two chamber view was obtained when obvious attenuation artefacts in the lateral-or anterior basal segments were seen. If a contrast defect was limited to the anterior-or lateral basal segment the defect was attributed to attenuation.
Quantitative analysis using regions of interest. For quantitative analysis regions of interest were placed from epi-to endocardium in 16 myocardial segments. Contrast intensity after flash was measured end-systolic (12) . Plots of contrast intensity versus time were constructed and fit to an exponential function y=A*(1-e -βt ) (13) . The plateau of signal intensity (A) and the slope of maximal signal intensity rise (β) were measured and the product of A*β was calculated.
Receiver operating characteristics analysis of flow parameters was performed to select the best cut-off value for viability detection. 
b) In clinical studies.
In clinical studies myocardial viability by MPI was assessed qualitatively on a segmental level. We hypothesized that segments coded red or dark red would have low probability to recover contractile function after revascularization (nonviable segments).
Thus, segments predominantly coded red or dark red were classified as nonviable and segments predominantly coded yellow or green were identified as viable. By this approach we sought to compare the accuracy of visual analysis with quantitative estimation of blood flow by regions of interest and with MPI. Functional recovery at 3-6 months of follow-up deemed as the standard reference. We also assumed that by this approach the reproducibility and the accuracy of MCE to detect viable myocardium could be increased. The time spent for the assessment of myocardial perfusion by each of the three methods was measured in 20 representative images.
Statistical Analysis. Data are presented as mean ± standard deviation. Agreement between observers was assessed using kappa statistics (14) . Visually guided planimetry of perfusion defect area was compared with MPI and with standard techniques using linear regression analysis and Bland-Altman statistics (15) . Receiver operating characteristics were used to assess the diagnostic value of quantitative MCE parameters and differences in diagnostic value were evaluated by McNemar χ² test (4-7). Differences were considered significant at p<0.05.
Results
Experimental studies
Determination of perfusion-defect-size-to-risk-area-ratio. MPI allowed objective risk area delineation during LAD occlusion and infarct size determination during reperfusion (Fig. 1) .
MPI of myocardial blood flow (A*β-images) correlated significantly closer with histological (Table 3) 
Discussion
Myocardial parametric imaging is less time-consuming than off-line processing by regions of interest, less operator dependent than visual analysis and shows high spatial resolution.
MPI correlates closer with standard techniques for viability assessment in experimental studies and demonstrates more preferable specificity for viability detection in humans.
Experimental studies. Linka et al (8) first introduced parametric analysis of contrast images using peak intensity and peak rate of rise of intensity. This approach was based upon the use of triggered imaging modalities and requires background subtraction of individual frames obtained during increasing trigger intervals to select contrast specific signals. High power imaging modalities require end-systolic triggering over several seconds. Stable imaging conditions to prevent patient and observer related motion artefacts are therefore mandatory (16) .
Such artefacts can be more easily recognised and avoided with newer real-time techniques.
Furthermore, as tissue nonlinearity can be ignored in low power imaging (17), baseline subtraction is deemed unnecessary by real-time MCE. We have previously demonstrated the potential of real-time MCE to assess the dynamics of postischemic microvascular dysfunction (2, 18) and the usefulness of first-harmonic Fourier algorithms to display myocardial perfusion in a parametric format, which allows an objective evaluation of real-time MCE in animal studies (19) .
In the present study we used a simple, commercially available software tool to quantify tissue viability in the experimental setting of myocardial infarction. Visual MCE confirmed ischemia during LAD occlusion and reappearance of a marked perfusion defect 2 hours after reperfusion.
Visual assessment of risk area and infarct size corresponded with standard histological techniques. We have previously reported an r² value of 0.86 for visually guided planimetry in pigs receiving soluble P-selectin to reduce myocardial ischemia-reperfusion injury (2) . In the present study no cardioprotective agents were applied so that perfusion defect size was larger.
This may have influenced the variability in visually guided perfusion defect planimetry, resulting in a lower r² value of 0.56. Nevertheless, visually guided planimetry was still significantly related with histological findings (p<0.01). As the variability for perfusion defect assessment by MPI was significantly lower, the correlation coefficient between MPI and histology remained high Clinical studies. In patients with ischemic heart disease revascularization is associated with improvement of left ventricular function and better clinical outcomes, when viability is present (21). We and others previously evaluated the role of MCE in detecting myocardial viability in stable ischemic heart disease using intravenous contrast administration (3-4).
However, there is still to the best of our knowledge no published report investigating the value of MPI for viability assessment in humans. Having demonstrated the usefulness of MPI to assess myocardial tissue viability in experimental studies we sought to determine the potential of parametric quantification to improve the diagnostic accuracy of visual MCE for viability detection in patients with ischemic heart disease. Assessment of tissue perfusion by both triggered and real-time techniques suffers from several restrictions, including inhomogeneous distribution of regional contrast opacification, attenuation, contrast drop out in basal segments and blooming (24). These limitations reduce the specificity of MCE to detect myocardial viability by visual criteria (3-4, 22-23). We and others have previously shown that complex and time consuming quantification of regional myocardial blood flow parameters including normalization of regional myocardial blood volume to normal myocardium are necessary, in order to improve the specificity of the technique (3) (4) . Chronic ischemic heart disease is associated with myocardial fibrosis and increased collagen content causing decrease in capillary density and particularly of blood volume (3). Thus, it is not surprising that parametric quantification of blood volume provided the most preferable specificity for viability detection in accord with previous clinical studies (4). Myocardial parametric quantification provides automatic calculation of contrast replenishment kinetics in multiple pixels of the myocardium, which are then colourencoded on a linear scale according to a normal value adjusted to the entire myocardium. This is the first study to demonstrate that by parametric quantification of blood volume heterogeneity of contrast distribution can be reduced and the specificity of the technique for viability detection can be significantly improved from 43% to 66%. However, the sensitivity of MPI to detect viability was comparable to visual assessment (88% versus 86%) and the increase in accuracy was not statistically significant by McNemar χ²-test (81% versus 73%, p=ns). As parametric imaging demonstrates lower observer variability and requires less experience for the interpretation of myocardial perfusion this method may be of particular interest for novice interpreters.
Limitations. In accord with previous studies, we chose recovery of contractile function after revascularization as a standard reference for assessment of myocardial viability (4, 11) because the latter is an important clinical goal. However, it should be recognized that microvascular integrity in the mid-and epicardial layer may be clinically important in other ways such as protection against left ventricular remodeling even in absence of functional recovery (25). 
